Janssen Korea, Johnson & Johnson (J&J)'s pharmaceutical division in Korea, said that Christian Rodseth was appointed as the J&J Innovative Medicine Area Managing Director of North Asia on Monday.
In his new role, Rodseth will serve as the Managing Director of Janssen Korea and will oversee the pharmaceutical operations for J&J in North Asia, including Korea, Taiwan, and Hong Kong.
Rodseth joined J&J in 2006 as a sales representative in South Africa and has since held various leadership roles in sales, marketing, and strategic planning across several regions, including Africa, Europe, and the U.S.
Most recently, he served as the Vice President and Managing Director overseeing five European countries, including Greece, Cyprus, Malta, Poland, and Romania, where he led significant business growth in Europe.
He has also contributed to enhancing access to innovative treatments through his active involvement in pharmaceutical industry associations in multiple countries.
"I am thrilled to lead a dedicated team committed to driving healthcare innovation in such dynamic markets as Korea, Taiwan, and Hong Kong," Rodseth said. "I look forward to collaborating with healthcare professionals, governments, and patients to address complex diseases, improve access to innovative medicines, and ultimately, save lives and transform lives."
Rodseth holds degrees from the University of the Witwatersrand in South Africa and Warwick Business School in the U.K.
Related articles
- Janssen's bispecific antibody drug for multiple myeloma wins nod in Korea
- Janssen Korea to cease supply of antifungal drug Sporanox Sol
- Darzalex’s reimbursement has been in limbo for 3 years. Will it be different this time?
- Janssen's Rybrevant makes 3rd attempt for reimbursement. Will it succeed?
- Yuhan to receive $60 million milestone from Janssen for NSCLC drug lazertinib
- J&J Innovative Medicine’s Balversa offers new hope for urothelial cancer patients with FGFR mutations
- Korean multiple myeloma survival rates lag behind developed nations, expert calls for better drug access
- Enclony partners with Johnson & Johnson on drug sample inspection project
- SK plasma to exclusively distribute Janssen's blood cancer drug Velcade in Korea
